Skip to main content

Sarcoma.

23 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Sarcoma23 studies

RhabdomyosarcomaPhase 1NCT06865664Papers

FGFR4-CAR T Cells

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

National Cancer Institute (NCI)Open the brief

Relapsed/Refractory Pediatric SarcomaPhase 1/2NCT05634369

TGFβ-Imprinted NK Cells + Gemcitabine/Docetaxel

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

Nationwide Children's HospitalOpen the brief

Clinical trials: Phase 1 and Phase 2, explained